Bharat Biotech

Omicron Is Behaving More Rationally Than Politicians And Media, Who Are Part Of The Problem
Omicron Is Behaving More Rationally Than Politicians And Media, Who Are Part Of The ProblemR JagannathanJan 6, 2022 10:54 AM
Bharat Biotech Gets DCGI Panel's Approval For Phase 3 Trials Of Intranasal COVID-19 Vaccine As Booster Shot: Report
Bharat Biotech Gets DCGI Panel's Approval For Phase 3 Trials Of Intranasal COVID-19 Vaccine As Booster Shot: ReportSwarajya StaffJan 5, 2022 11:59 AM
Bharat Biotech's Intranasal Covid-19 Vaccine Completes Phase 2 Trials: Krishna Ella
Bharat Biotech's Intranasal Covid-19 Vaccine Completes Phase 2 Trials: Krishna EllaBhaswati Guha Majumder Nov 29, 2021 12:53 PM
UK Adds Bharat Biotech's Covaxin To Its List Of Approved COVID-19 Vaccines For International Travellers
UK Adds Bharat Biotech's Covaxin To Its List Of Approved COVID-19 Vaccines For International TravellersSwarajya StaffNov 23, 2021 05:23 AM
Lost 10 Years Of Life In Past 18 Months Due To Stress And Excitement Of Developing Covaxin: Dr Krishna Ella
Lost 10 Years Of Life In Past 18 Months Due To Stress And Excitement Of Developing Covaxin: Dr Krishna Ella Swarajya StaffNov 14, 2021 03:27 AM
Bharat Biotech Chairman Dr Krishna Ella Slams Biased Media Coverage And Domestic Politics Around Covaxin: "It Really Hurts"
Bharat Biotech Chairman Dr Krishna Ella Slams Biased Media Coverage And Domestic Politics Around Covaxin: "It Really Hurts"Swarajya StaffNov 12, 2021 10:04 AM
Covaxin Phase 3 Trial Data Shows 77.8 Per Cent Efficacy Against Symptomatic COVID, Finds Study Published In Lancet
Covaxin Phase 3 Trial Data Shows 77.8 Per Cent Efficacy Against Symptomatic COVID, Finds Study Published In LancetSwarajya StaffNov 12, 2021 04:35 AM
Booster Doses? Vaccination For Children? SUTRA Team Answers Your Questions
Booster Doses? Vaccination For Children? SUTRA Team Answers Your QuestionsThe SUTRA TeamNov 10, 2021 06:13 AM
Zydus Cadila To Enter Vaccine Space By Supplying 1 Crore Of Its Plasmid DNA Vaccine Shots To Centre; Read Other Details Here
Zydus Cadila To Enter Vaccine Space By Supplying 1 Crore Of Its Plasmid DNA Vaccine Shots To Centre; Read Other Details HereBhaswati Guha Majumder Nov 9, 2021 07:27 AM
US Biotech Company Ocugen Files IND Application With FDA For Bharat Biotech's Covaxin Clinical Trials
US Biotech Company Ocugen Files IND Application With FDA For Bharat Biotech's Covaxin Clinical TrialsBhaswati Guha Majumder Oct 28, 2021 09:03 AM
WHO Seeks 'Additional Clarifications' From Bharat Biotech For Covaxin To Conduct Final 'Risk-Benefit Assessment'
WHO Seeks 'Additional Clarifications' From Bharat Biotech For Covaxin To Conduct Final 'Risk-Benefit Assessment' PTIOct 27, 2021 04:24 AM
What Can Possibly Explain WHO's Delay In Approving Covaxin?
What Can Possibly Explain WHO's Delay In Approving Covaxin?Bhaswati Guha Majumder Oct 20, 2021 01:46 PM
Bharat Biotech's Covaxin For Children To Get Approval For Emergency Use; Two Other Vaccines Are On The Pipeline
Bharat Biotech's Covaxin For Children To Get Approval For Emergency Use; Two Other Vaccines Are On The PipelineBhaswati Guha Majumder Oct 13, 2021 07:30 AM
GSK-Bharat Biotech Partnership To Produce World's First Malaria Vaccine Approved By WHO
GSK-Bharat Biotech Partnership To Produce World's First Malaria Vaccine Approved By WHOSwarajya StaffOct 8, 2021 05:03 AM
Final Decision On Approval To Bharat Biotech's Covaxin To Be Taken Next Week: WHO
Final Decision On Approval To Bharat Biotech's Covaxin To Be Taken Next Week: WHOSwarajya StaffOct 6, 2021 05:08 AM
India To Buy 27-28 Crore COVID-19 Vaccine Doses From SII, Bharat Biotech In October: Report
India To Buy 27-28 Crore COVID-19 Vaccine Doses From SII, Bharat Biotech In October: ReportSwarajya StaffOct 1, 2021 05:02 AM
Serum Institute Receives Approval To Launch Covovax Trials On Children Aged 7-11
Serum Institute Receives Approval To Launch Covovax Trials On Children Aged 7-11Bhaswati Guha Majumder Sep 29, 2021 11:07 AM
Bharat Biotech Completes Phase 2/3 Trials Of Covaxin In Children Aged Below 18 Years
Bharat Biotech Completes Phase 2/3 Trials Of Covaxin In Children Aged Below 18 YearsSwarajya StaffSep 22, 2021 08:05 AM
WHO's Emergency Use Nod For Bharat Biotech's Covaxin Delayed Till 5 October: Report
WHO's Emergency Use Nod For Bharat Biotech's Covaxin Delayed Till 5 October: ReportSwarajya StaffSep 18, 2021 04:33 AM
Bharat Biotech's Covaxin May Get WHO's Approval By End Of September, Says Dr V K Paul
Bharat Biotech's Covaxin May Get WHO's Approval By End Of September, Says Dr V K PaulSwarajya StaffSep 16, 2021 11:10 AM
Load More